Literature DB >> 25776444

Hyperuricemia starts at 360 micromoles (6 mg/dL).

Thomas Bardin1.   

Abstract

Entities:  

Keywords:  Cardiovascular risk; Gout; Hyperuricemia; Threshold; Uricemia

Mesh：

Substances：

Year:  2015        PMID： 25776444     DOI： 10.1016/j.jbspin.2015.01.002

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  8 in total

1.  Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study.

Authors:  Giovambattista Desideri; Agostino Virdis; Edoardo Casiglia; Claudio Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-02-09

Review 2.  Hyperuricemia, Gout, and the Brain-an Update.

Authors:  Augustin Latourte; Julien Dumurgier; Claire Paquet; Pascal Richette
Journal:  Curr Rheumatol Rep       Date:  2021-12-30       Impact factor: 4.592

3.  The benchmark dose estimation of reference levels of serum urate for gout.

Authors:  Xiao Chen; Zhongqiu Wang; Na Duan; Wenjing Cui; Xiaoqiang Ding; Taiyi Jin
Journal:  Clin Rheumatol       Date:  2018-08-25       Impact factor: 2.980

4.  A single-centre experience of febuxostat as a second-line urate-lowering therapy.

Authors:  Swee Gaik Ong; Hui Jen Ding
Journal:  Malays Fam Physician       Date:  2021-01-31

5.  Metabolic syndrome, serum uric acid and renal risk in patients with T2D.

Authors:  Francesca Viazzi; Pamela Piscitelli; Carlo Giorda; Antonio Ceriello; Stefano Genovese; Giuseppina Russo; Pietro Guida; Paola Fioretto; Salvatore De Cosmo; Roberto Pontremoli
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

6.  Knowledge and practice in the management of asymptomatic hyperuricemia among primary health care physicians in Jeddah, Western Region of Saudi Arabia.

Authors:  Norah A Alqarni; Abdul H Hassan
Journal:  Saudi Med J       Date:  2018-12       Impact factor: 1.484

7.  Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat.

Authors:  L Messer; R Felten; L Widawski; T Fabacher; L Spielmann; J E Gottenberg; J Sibilia; P M Duret
Journal:  Clin Rheumatol       Date:  2022-01-20       Impact factor: 3.650

8.  Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities.

Authors:  Mengying Sun; Ana I Vazquez; Richard J Reynolds; Jasvinder A Singh; Mathew Reeves; Tony R Merriman; Angelo L Gaffo; Gustavo de Los Campos
Journal:  Arthritis Res Ther       Date:  2018-05-03       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.